JPH0723774A - Lactic acid bacterium containing docosahexaenoic acid and method for producing the same - Google Patents
Lactic acid bacterium containing docosahexaenoic acid and method for producing the sameInfo
- Publication number
- JPH0723774A JPH0723774A JP5168980A JP16898093A JPH0723774A JP H0723774 A JPH0723774 A JP H0723774A JP 5168980 A JP5168980 A JP 5168980A JP 16898093 A JP16898093 A JP 16898093A JP H0723774 A JPH0723774 A JP H0723774A
- Authority
- JP
- Japan
- Prior art keywords
- lactic acid
- docosahexaenoic acid
- acid
- acid bacterium
- producing
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Landscapes
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Description
【0001】[0001]
【産業上の利用分野】本発明は、乳酸菌を高度不飽和脂
肪酸として実質的にドコサヘキサエン酸のみを含有する
ことを特徴とする海洋性微細藻類の抽出物を添加した培
地で培養する乳酸菌の製造方法に関する。このような乳
酸菌は、高度不飽和脂肪酸として実質的にドコサヘキサ
エン酸のみを含有し、食品、化粧品、水産、化成品など
の分野において有用である。FIELD OF THE INVENTION The present invention relates to a method for producing a lactic acid bacterium, which comprises culturing a lactic acid bacterium as a highly unsaturated fatty acid substantially containing docosahexaenoic acid in a medium containing an extract of marine microalgae. Regarding Such a lactic acid bacterium substantially contains only docosahexaenoic acid as a highly unsaturated fatty acid, and is useful in fields such as foods, cosmetics, marine products, and chemical products.
【0002】[0002]
【従来の技術】乳酸菌は、本来有している薬理作用とし
て、 1)腸内で増殖し、有害菌の定着を阻止する物質を産生
したり、有害菌の定着場所を占拠する、2)腸内では増
殖しないが、その菌体成分が有効物質として働き、直接
生体の免疫力を高めたり、コレステロールの吸収を阻止
したり、あるいは腸内菌叢の改善に作用する、さらに、
3)腸内において、腸内有害菌によって生成される菌体
内毒素、エンテロトキシン、アミン、アンモニアなどの
生成を抑制するなどの事実が広く知られている。そのた
め、より広く利用されているが、乳酸菌の菌体中の脂肪
酸組成の成分は、パルミチン酸、パルミトオレイン酸、
オレイン酸が主であって、これらの脂肪酸の栄養的、薬
理的価値は乏しい上、高度不飽和脂肪酸は一切含有され
ていない。2. Description of the Related Art Lactic acid bacteria have, as their inherent pharmacological actions, 1) growth in the intestine, production of substances that prevent colonization of harmful bacteria, and occupation of colonization sites of harmful bacteria, 2) intestine. Although it does not proliferate in the body, its bacterial component acts as an active substance, directly enhances the immunity of the living body, blocks the absorption of cholesterol, or acts on the improvement of intestinal flora.
3) The fact that the production of endotoxins, enterotoxins, amines, ammonia and the like produced by harmful enterobacteria in the intestine is suppressed is widely known. Therefore, although more widely used, the components of the fatty acid composition in the cells of lactic acid bacteria are palmitic acid, palmitooleic acid,
It is mainly oleic acid, and these fatty acids have poor nutritional and pharmacological values, and they do not contain any polyunsaturated fatty acids.
【0003】一方、ω−3系列のドコサヘキサエン酸
は、ω−6系列の高度不飽和脂肪酸の前駆体として、抗
腫瘍、抗動脈硬化、抗炎症などの作用の他、脂質低下作
用、コレステロール低下作用、視力低下の抑制、記憶改
善などの作用が知られている。ω−6系列の高度不飽和
脂肪酸は、陸棲の動物油脂、植物の根などに含まれてお
り、現在の食生活において十分摂取可能であるが、ω−
3系列の高度不飽和脂肪酸であるドコサヘキサエン酸は
海産生物に特有の脂肪酸であり、肉食嗜好にある世代に
とっては不足がちである。海産生物由来の食品が避けら
れがちである大きな要因はその特有の臭いにある。ドコ
サヘキサエン酸も海産物の臭いの一成分であるが、海産
物の臭いの主体は、酸化分解生成物のアルデヒド等に由
来する。従って、ドコサヘキサエン酸を酸化が困難な形
状で食品に添加出来ることが好ましい。On the other hand, the ω-3 series of docosahexaenoic acid is a precursor of the ω-6 series of highly unsaturated fatty acids, and has anti-tumor, anti-arteriosclerotic, anti-inflammatory and other effects, as well as a lipid-lowering effect and a cholesterol-lowering effect. It is known to suppress the deterioration of visual acuity and improve memory. The ω-6 series of highly unsaturated fatty acids are contained in terrestrial animal fats and oils, plant roots, etc., and can be ingested sufficiently in the present dietary life.
Docosahexaenoic acid, which is a series of highly unsaturated fatty acids, is a fatty acid specific to marine products, and tends to be insufficient for the generations who are carnivorous. A major factor that tends to avoid foods derived from marine products is their unique odor. Docosahexaenoic acid is also a component of the odor of marine products, but the main odor of marine products is derived from oxidative decomposition products such as aldehydes. Therefore, it is preferable that docosahexaenoic acid can be added to food in a form that is difficult to oxidize.
【0004】[0004]
【発明が解決しようとする問題点】本発明の目的は、乳
酸菌が本来持っている有用性を保持するとともに、栄養
上、薬理上価値のあるドコサヘキサエン酸を摂取し易く
するために高度不飽和脂肪酸としてドコサヘキサエン酸
を含有する乳酸菌を提供することにある。DISCLOSURE OF THE INVENTION Problems to be Solved by the Invention The purpose of the present invention is to maintain the usefulness inherent in lactic acid bacteria and to facilitate the intake of docosahexaenoic acid, which is of nutritional and pharmacological value, to make it highly unsaturated fatty acid. Another object is to provide a lactic acid bacterium containing docosahexaenoic acid.
【0005】[0005]
【問題点を解決するための手段】本発明者らは、上記の
目的のために鋭意研究の結果、ドコサヘキサエン酸を高
濃度に産生し、藻体内に蓄積・含有する海洋性微細藻
類、特にクリプテコディニウム・コーニーの抽出物を添
加して培養した乳酸菌の脂質について、1)ドコサヘキ
サエン酸を含有する乳酸菌の菌体を蒸留水、界面活性剤
で洗浄しても、その乳酸菌の菌体中のドコサヘキサエン
酸の量が総脂肪酸の30%以上と高いこと、2)本発明
で用いる乳酸菌の増殖速度は早く、多量の菌体を短時間
の中に得ることが出来ることを見いだし、本発明に至っ
た。[Means for Solving the Problems] As a result of earnest research for the above-mentioned purpose, the present inventors have produced marine microalgae that produce docosahexaenoic acid at a high concentration and accumulate / contain it in algal cells, especially crypts. Regarding lipids of lactic acid bacteria cultivated by adding the extract of tecodinium cohnii: 1) Even if the lactic acid bacteria cells containing docosahexaenoic acid were washed with distilled water and a surfactant, It was found that the amount of docosahexaenoic acid is as high as 30% or more of the total fatty acid, 2) the growth rate of the lactic acid bacterium used in the present invention is fast, and a large amount of microbial cells can be obtained in a short time, leading to the present invention. It was
【0006】すなわち、本発明は、高度不飽和脂肪酸と
して実質的にドコサヘキサエン酸のみを含有するドコサ
ヘキサエン酸を含有する乳酸菌を提供する。さらに、海
洋性微細藻類の藻体の自己消化物を添加した培地で乳酸
菌を培養するドコサヘキサエン酸を含有する乳酸菌の製
造方法を提供する。また、海洋性微細藻類の藻体からの
抽出物を添加した培地で乳酸菌を培養するドコサヘキサ
エン酸を含有する乳酸菌の製造方法を提供する。そし
て、前記海洋性微細藻類が、クリプテコディニウム・コ
ーニー(Crypthecodinium cohnii)であるのが好まし
い。また、前記抽出物が、エタノール、エタノール/水
混合物、ヘキサン、エタノール/ヘキサン混合物、メタ
ノール/クロロホルム混合物またはメタノール/水混合
物のいずれか1種または2種以上の溶媒で抽出されたも
のであるのが好ましい。That is, the present invention provides a lactic acid bacterium containing docosahexaenoic acid containing substantially only docosahexaenoic acid as a highly unsaturated fatty acid. Further provided is a method for producing a lactic acid bacterium containing docosahexaenoic acid, which comprises culturing a lactic acid bacterium in a medium to which an autolysate of an alga body of a marine microalga is added. Also provided is a method for producing a lactic acid bacterium containing docosahexaenoic acid, which comprises culturing a lactic acid bacterium in a medium to which an extract from an algal body of a marine microalga is added. The marine microalgae is preferably Crypthecodinium cohnii. The extract is extracted with one or more solvents of ethanol, ethanol / water mixture, hexane, ethanol / hexane mixture, methanol / chloroform mixture or methanol / water mixture. preferable.
【0007】以上のような知見に基づいて完成されたも
ので、乳酸菌を高度不飽和脂肪酸として実質的にドコサ
ヘキサエン酸のみを高濃度に含む海洋性微細藻類、特
に、クリプテコディニウム・コーニーの自己消化物また
は抽出物を添加した培地中にて培養することを特徴とす
るドコサヘキサエン酸を含有する乳酸菌およびその製造
方法である。The present invention was completed on the basis of the above findings, and is based on the self-administration of marine microalgae containing lactic acid bacteria as polyunsaturated fatty acids and containing docosahexaenoic acid alone at a high concentration, especially Crypthecodinium cornii. A lactic acid bacterium containing docosahexaenoic acid, which comprises culturing in a medium to which a digested product or an extract is added, and a method for producing the same.
【0008】(作用)本発明において利用する海洋性微
細藻類は、高度不飽和脂肪酸としてドコサヘキサエン酸
を生成する藻類であればよく、たとえば、クリプテコデ
ィニウム(Crypthecodinium)属に属する藻類、特に、ク
リプテコディニウム・コーニー(Crypthecodinium cohn
ii)種などがある。これらは公知の藻類であり、たとえ
ばATCC(American Type Culture Collection)など
の保存機関より入手可能である。具体例としては、クリ
プテコディニウム・コーニーATCC30021,30
543,30556,30571,30572,305
75,50051,50053,50055,5005
6,50058,50060等が挙げられる。特に、ク
リプテコディニウム・コーニーATCC30021株
は、DHAの産生量が高いので好ましい。(Operation) The marine microalgae used in the present invention may be any algae that produces docosahexaenoic acid as a highly unsaturated fatty acid, and for example, algae belonging to the genus Crypthecodinium, particularly, crypt Crypthecodinium cohn
ii) There are species. These are known algae, and are available from preservation organizations such as ATCC (American Type Culture Collection). As a specific example, Crypthecodinium cornie ATCC 30021,30
543, 30556, 30571, 30572, 305
75, 50051, 50053, 50005, 5005
6,50058,50060 and the like. In particular, the Crypthecodinium cohnii ATCC30021 strain is preferable because it produces a high amount of DHA.
【0009】本発明において利用する海洋性微細藻類の
藻体は、以下の培養方法によって得ることができる。海
洋性微細藻類の培養のための培地としては、この藻類が
良好に成育出来る培地であればいかなる組成の培地も使
用出来る。培養方法としては、静置培養、液体振盪培
養、液体タンク培養、回分培養、硫加培養、連続培養な
どいかなる培養方法でもよい。培養条件は、培養温度1
5〜30℃、培養時間2〜8日で培養を行う。使用する
藻体としては、培養終了後の培養液から抽出、あるいは
濾過、遠心分離などにより回収して得られる湿生藻体、
藻体ペースト、あるいはさらに加熱、凍結乾燥または噴
霧して得られる加熱乾燥品、凍結乾燥品、噴霧乾燥品な
どの乾燥藻体であってもよい。The algal bodies of marine microalgae used in the present invention can be obtained by the following culture method. As a medium for culturing the marine microalgae, a medium having any composition can be used as long as the medium can grow well. The culture method may be any culture method such as static culture, liquid shaking culture, liquid tank culture, batch culture, sulphate culture, and continuous culture. Culture conditions are culture temperature 1
Culturing is performed at 5 to 30 ° C. and a culturing time of 2 to 8 days. The algal cells to be used include a wet algal cell obtained by extraction from the culture solution after completion of the culture, or filtration or recovery by centrifugation or the like,
It may be an algal cell paste, or a dried algal cell such as a heat-dried product, a freeze-dried product or a spray-dried product obtained by further heating, freeze-drying or spraying.
【0010】本発明は、得られた藻体を自己消化させた
自己消化物、または、藻体から抽出した抽出物を使用す
る。The present invention uses the self-digested product obtained by self-digesting the obtained algal cells or the extract extracted from the algal cells.
【0011】藻体の自己消化物は、湿生藻体または乾燥
藻体を少量の滅菌水で懸濁させた藻体懸濁液の液表面を
p−キシレンやトルエン等で覆い、35℃以上〜50℃
に加温して徐々に自己消化させる。自己消化には、2〜
48時間の時間を掛ける。消化完了後、p−キシレンま
たはトルエン、藻体細胞残渣を遠心分離などにより除去
し、減圧蒸留、凍結乾燥などにより濃縮して調製する。
調製された藻体の自己消化物は、主として脂質で、ドコ
サヘキサエン酸を10〜80重量%含有する。The self-digested product of algal cells is obtained by covering the liquid surface of an algal cell suspension obtained by suspending wet algal cells or dried algal cells with a small amount of sterile water with p-xylene, toluene, etc. ~ 50 ° C
Warm up to gradually self-extinguish. 2 to self-digestion
It takes 48 hours. After completion of the digestion, p-xylene or toluene and algal cell residue are removed by centrifugation or the like, and concentrated by vacuum distillation, freeze-drying or the like to prepare.
The prepared self-digested product of algal cells is mainly a lipid and contains 10 to 80% by weight of docosahexaenoic acid.
【0012】藻体からの抽出物は、藻体の培養液、ある
いは、湿生藻体または乾燥藻体を少量の滅菌水で懸濁さ
せた藻体懸濁液を下記の抽出溶媒を用い、20〜60℃
で、常法通り抽出して得ることができる。藻体からの抽
出物は、主として脂質(またはエステル)で、ドコサヘ
キサエン酸を20〜90重量%含有する。抽出溶媒とし
ては、エタノール、メタノール、ヘキサン、エタノール
/水混合物、エタノール/ヘキサン混合物、メタノール
/クロロホルム混合物またはメタノール/水混合物のい
ずれか1種または2種以上の溶媒が挙げられる。混合物
で用いる場合、例えば、エタノール:水の混合比は、
2:98〜98:2、エタノール:ヘキサンの混合比
は、1:99〜99:1である。The extract from algal cells is a culture solution of algal cells, or an algal cell suspension obtained by suspending wet algal cells or dried algal cells with a small amount of sterilized water using the following extraction solvent: 20-60 ° C
It can be obtained by extraction in the usual way. The extract from algal cells is mainly a lipid (or ester) and contains 20 to 90% by weight of docosahexaenoic acid. Examples of the extraction solvent include any one solvent or two or more solvents of ethanol, methanol, hexane, an ethanol / water mixture, an ethanol / hexane mixture, a methanol / chloroform mixture, or a methanol / water mixture. When used in a mixture, for example, the mixing ratio of ethanol: water is
The mixing ratio of 2:98 to 98: 2 and ethanol: hexane is 1:99 to 99: 1.
【0013】抽出物は、水不溶性の抽出溶媒であるヘキ
サン、クロロホルムを留去すれば、エタノール等の水溶
性の溶媒はそのままで乳酸菌の培養に使用出来る。な
お、(必要に応じて溶媒を留去した)抽出物を乳酸菌の
培養に使用する場合には、抽出物または自己消化物のp
Hは、6〜8.5が好ましい。The extract can be used for culturing lactic acid bacteria without removing the water-insoluble extraction solvent, such as hexane and chloroform, by leaving the water-soluble solvent such as ethanol as it is. When the extract (the solvent is distilled off if necessary) is used for culturing lactic acid bacteria, p or p
H is preferably 6 to 8.5.
【0014】ここで、高度不飽和脂肪酸とは、不飽和度
が2以上の不飽和脂肪酸をいい、高度不飽和脂肪酸の混
合油脂、例えば、イワシ、サバ、アジ、マグロ由来の油
脂、それも、総脂肪酸中の高度不飽和脂肪酸の占める割
合が10%以上の油脂で、かつ、高度不飽和脂肪酸とし
てリノール酸、γ−リノレイン酸、アラキドン酸、α−
リノレイン酸、エイコサペンタエン酸、ドコサヘキサエ
ン酸およびこれらの塩類、エステル類、トリアシルグリ
セロール、ジアシルグリセロール、モノアシルグリセロ
ール、グリセロリン脂質、グリセロ糖脂質、スフィンゴ
リン脂質、スフィンゴ糖脂質等多くの各種油脂を使って
各種の高度不飽和脂肪酸を乳酸菌に同時に蓄積させる方
法はすでに公知(特開平4−341180号)である
が、この方法では各種の高度不飽和脂肪酸を含有する
上、特定の高度不飽和脂肪酸生成比率のコントロールが
出来ず、ドコサヘキサエン酸のみを単独で含有させるこ
とは困難であり、かつ、ドコサヘキサエン酸のみを単独
で使用するにはその分離・分画と精製に多大の労力と経
費を必要とするために使用用途が限定される問題点があ
る。本発明の特徴は、高度不飽和脂肪酸として実質的に
ドコサヘキサエン酸のみを選択的に乳酸菌に高濃度に蓄
積させることにあり、このことによってドコサヘキサエ
ン酸のみを使用したい用途に効率的に使用が可能となっ
た。The term "polyunsaturated fatty acid" as used herein means an unsaturated fatty acid having a degree of unsaturation of 2 or more, and mixed fats and oils of highly unsaturated fatty acids, for example, fats and oils derived from sardines, mackerel, horse mackerel, and tuna, and the like. Fats and oils in which the proportion of highly unsaturated fatty acids in the total fatty acids is 10% or more, and as highly unsaturated fatty acids, linoleic acid, γ-linolenic acid, arachidonic acid, α-
Linoleic acid, eicosapentaenoic acid, docosahexaenoic acid and their salts, esters, triacylglycerols, diacylglycerols, monoacylglycerols, glycerophospholipids, glyceroglycolipids, sphingophospholipids, glycosphingolipids, etc. A method for simultaneously accumulating various polyunsaturated fatty acids in lactic acid bacteria is already known (JP-A-4-341180). However, in this method, various polyunsaturated fatty acids are contained and a specific polyunsaturated fatty acid production ratio is also included. Since it is difficult to control docosahexaenoic acid alone, it is difficult to contain only docosahexaenoic acid alone, and using only docosahexaenoic acid alone requires great labor and cost for its separation, fractionation and purification. There is a problem that the use is limited. A feature of the present invention is that substantially only docosahexaenoic acid as a polyunsaturated fatty acid is selectively accumulated in a lactic acid bacterium at a high concentration, which enables efficient use in applications where only docosahexaenoic acid is desired to be used. became.
【0015】本発明に用いる乳酸菌は、糖を乳酸発酵す
る細菌であればいかなる細菌であってもよく、特に属、
種あるいは株などを限定されるものではないが、例え
ば、エンテロコッカス(Enterococcus)属、ラクトバチル
ス(Lactobacillus)属、ビフィドバクテリウム(Bifidob
acterium) 属に属するもの、特に、エンテロコッカス・
フェカリス(Enterococcus faecalis) 種が挙げられる。
これらの乳酸菌については、例えば、IFO((財)発
酵研究所=INSTITUTEFOR FERMENTATION, OSAKA)など微
生物寄託機関などから容易に入手可能である。The lactic acid bacterium used in the present invention may be any bacterium as long as it is a lactic acid-fermenting bacterium of sugar,
Although the species or strain is not limited, for example, Enterococcus genus, Lactobacillus genus, Bifidobacterium (Bifidob)
acterium), especially Enterococcus
Fecalis (Enterococcus faecalis) species may be mentioned.
These lactic acid bacteria can be easily obtained from microbial deposit institutions such as IFO (Institute for Fermentation, Osaka).
【0016】本発明の乳酸菌の製造方法では、乳酸菌
を、海洋性微細藻類の藻体から得た自己消化物あるいは
抽出物を含有する培地で培養する。本発明の乳酸菌の製
造方法に用いる培地としては、通常の乳酸菌が生育でき
る培地に海洋性微細藻類の藻体由来の自己消化物あるい
は抽出物を添加したものを用いる。ここで、通常の乳酸
菌が生育できる培地としては、例えば表1に示す組成の
培地を用いることが出来る。In the method for producing lactic acid bacteria of the present invention, the lactic acid bacteria are cultivated in a medium containing an autolyzed product or an extract obtained from the algal bodies of marine microalgae. As a medium used in the method for producing lactic acid bacteria of the present invention, a medium in which a normal lactic acid bacterium can grow and which is added with an autolysate or an extract derived from an algal body of a marine microalga is used. Here, as a medium in which ordinary lactic acid bacteria can grow, for example, the medium having the composition shown in Table 1 can be used.
【0017】 [0017]
【0018】海洋性微細藻類の藻体由来の自己消化物の
添加濃度は、培地中DHA換算量で0.001〜10重
量%、好ましくは0.002〜0.1重量%となるよう
に添加するのが乳酸菌の増殖およびドコサヘキサエン酸
の取り込み率からみても望ましい。また、藻体由来の抽
出物を用いる場合の添加量は、培地中0.01〜2.0
重量%であるのが好ましい。また、乳酸菌の培地に、ツ
イーン80(Tween80)等の乳化剤を添加しても
よい。The concentration of the self-digesting substance derived from the algal bodies of the marine microalgae is 0.001 to 10% by weight, preferably 0.002 to 0.1% by weight, calculated as DHA in the medium. It is desirable to do so from the viewpoint of the growth of lactic acid bacteria and the uptake rate of docosahexaenoic acid. In addition, the amount of addition when using an extract derived from algal cells is 0.01 to 2.0 in the medium.
It is preferably wt%. Further, an emulsifier such as Tween 80 may be added to the medium of lactic acid bacteria.
【0019】本発明の乳酸菌の製造方法において、乳酸
菌の培養方法は、通常、嫌気培養によって行う。培養器
を嫌気的条件、すなわち、乳酸菌が分子状酸素に触れな
いようにするためには、i)培地を容器内に満たした
後、加熱し溶存酸素を取り除いてから乳酸菌体を加え
る、ii)耐圧性の容器で真空あるいは減圧にして培養
する、iii)培地に還元剤を添加する等の方法を用い
ればよい。培養開始時の乳酸菌の添加量は、培地1ml
当たり106 〜107 個の細胞になるように乳酸菌の菌
体を添加すればよい。乳酸菌培養用の培地、乳酸菌およ
び海洋性微細藻類の藻体由来の抽出物または自己消化物
を含有する混合物を以下の培養条件で嫌気培養し、培養
液を得ることができる。乳酸菌の培養条件としては、p
Hは、培養により産成する乳酸などの酸により培養の過
程で変化するが、培養開始時に、6.0〜7.5である
のが好ましい。培養温度は、35℃付近であり、培養時
間は、16時間程度である。得られた培養液は、そのま
ま乳酸菌飲料、乳酸菌添加食品として使用することがで
きる。また、得られた培養液から、ろ過、遠心分離等に
より乳酸菌を分離し、蒸留水または2%グリセリンモノ
オレートを用いて洗浄した後、乳酸菌の湿潤菌体として
も、また、凍結乾燥、噴霧乾燥等により乾燥菌体として
もよい。In the method for producing lactic acid bacteria of the present invention, the lactic acid bacteria are usually cultured by anaerobic culture. In order to prevent the lactic acid bacteria from coming into contact with molecular oxygen in the incubator, i) in order to prevent the lactic acid bacteria from coming into contact with the molecular oxygen, i) after adding the lactic acid bacteria after heating the medium to remove dissolved oxygen, ii) A method such as culturing in a pressure-resistant container under vacuum or reduced pressure, and iii) adding a reducing agent to the medium may be used. The amount of lactic acid bacteria added at the start of culture is 1 ml of medium
The cells of lactic acid bacteria may be added so that 10 6 to 10 7 cells are obtained. A culture solution can be obtained by anaerobically culturing a mixture containing a lactic acid bacterium culture medium, an extract derived from an algal body of a lactic acid bacterium and a marine microalga or an autolysate under the following culture conditions. The culture conditions for lactic acid bacteria are p
H changes depending on the acid such as lactic acid produced by the culture in the course of the culture, but it is preferably 6.0 to 7.5 at the start of the culture. The culturing temperature is around 35 ° C., and the culturing time is about 16 hours. The obtained culture solution can be directly used as a lactic acid bacterium drink or a lactic acid bacterium-added food. In addition, lactic acid bacteria are separated from the obtained culture broth by filtration, centrifugation, etc., and washed with distilled water or 2% glycerin monooleate. For example, dried cells may be used.
【0020】このような培地で培養された乳酸菌の菌体
を凍結乾燥後、常法により三フッ化ホウ素メタノールに
てメチルエステル化すると、菌体中でエステル結合して
いるあらゆる脂肪酸誘導体の脂肪酸組成をガスクロマト
グラフィーで分析出来る。また、湿潤菌体あるいは乾燥
菌体を有機溶剤などを用いて抽出し、シリカゲル薄層ク
ロマトグラフィーにて脂質を分画した後、各々脂質の構
成脂肪酸を同様にして分析出来る。上述の方法により分
析した本発明の乳酸菌の菌体中の高度不飽和脂肪酸は、
実質的にドコサヘキサエン酸のみであった。After freeze-drying the cells of lactic acid bacteria cultured in such a medium and methyl-esterifying them with boron trifluoride methanol by a conventional method, the fatty acid composition of all fatty acid derivatives ester-bonded in the cells is obtained. Can be analyzed by gas chromatography. Alternatively, wet or dry cells can be extracted with an organic solvent or the like, and after fractionating the lipids by silica gel thin layer chromatography, the constituent fatty acids of the respective lipids can be similarly analyzed. The polyunsaturated fatty acid in the cells of the lactic acid bacterium of the present invention analyzed by the above method is
Substantially only docosahexaenoic acid.
【0021】[0021]
【実施例】以下、実施例により本発明をさらに具体的に
説明する。 (実施例1)クリプテコディニウム・コーニーATCC
30021の凍結乾燥体100gを40℃のエタノール
/ヘキサン(1/1)1リットルに加え、攪拌しながら
1時間抽出した後、この抽出液を10℃、8,000g
×15分間遠心分離して0.82リットル上清を得た。
これをエバポレーターで濃縮して、クリプテコディニウ
ム・コーニーの抽出物(20.2g,DHA含有量9.
7g)とした。EXAMPLES The present invention will be described in more detail below with reference to examples. (Example 1) Crypthecodinium cornie ATCC
100 g of the freeze-dried product of 30021 was added to 1 liter of ethanol / hexane (1/1) at 40 ° C., and the mixture was extracted for 1 hour with stirring.
It was centrifuged for 15 minutes to obtain 0.82 liter of supernatant.
This was concentrated with an evaporator, and an extract of Crypthecodinium cornii (20.2 g, DHA content of 9.
7 g).
【0022】(実施例2)エンテロコッカス・フェカリ
ス(Enterococcus faecalis)を表1の培地組成に実施例
1で得られたクプテコディニウム・コーニーの抽出物
0.2重量%(DHA換算で1.0g)を含有した培地
1Lを用いて、培養温度35℃で、16時間嫌気培養し
た。培養開始時のpHは、6.5であった。培養液から
細胞を遠心分離して集め、蒸留水で3回洗浄した菌体、
さらに0.1%グリセリンモノオレート水溶液で3回洗
浄した菌体を乾燥して乳酸菌粉末を得た。各洗浄条件下
での乳酸菌の乾燥粉末1.0gを14%三フッ化ホウ素
(BF3)メタノールに懸濁し、80℃、30分間反応
後、生成した脂肪三メチルエステルをGLCで分析し、
ドコサヘキサエン酸の含有量を定量した。Example 2 Enterococcus faecalis was added to the medium composition shown in Table 1 in an amount of 0.2% by weight of the extract of Kuptecodinium cornie obtained in Example 1 (1.0 g in terms of DHA). ) Was used for anaerobic culture at a culture temperature of 35 ° C. for 16 hours. The pH at the start of culture was 6.5. Cells collected from the culture solution by centrifugation, washed with distilled water three times,
Further, the bacterial cells washed three times with a 0.1% glycerin monooleate aqueous solution were dried to obtain lactic acid bacteria powder. 1.0 g of dry powder of lactic acid bacteria under each washing condition was suspended in 14% boron trifluoride (BF 3 ) methanol, reacted at 80 ° C. for 30 minutes, and the produced fatty trimethyl ester was analyzed by GLC.
The content of docosahexaenoic acid was quantified.
【0023】蒸留水で3回洗浄しただけの菌体では、ド
コサヘキサエン酸の菌体総脂肪酸に対する割合(乾燥菌
体1g当りの含有量)は45%で、他の不飽和脂肪酸は
含有していなかった。In the bacterial cells that were washed three times with distilled water, the ratio of docosahexaenoic acid to the total fatty acids of the bacterial cells (content per 1 g of dry bacterial cells) was 45%, and no other unsaturated fatty acids were contained. It was
【0024】同様に、0.1%グリセリンモノオレート
水溶液で3回洗浄した菌体でもドコサヘキサエン酸の含
有量は43%で、洗浄によるドコサヘキサエン酸の含有
量の低下はなく、また、ドコサヘキサエン酸以外の他の
高度不飽和脂肪酸も認められなかった。Similarly, the docosahexaenoic acid content was 43% even in the bacterial cells washed three times with a 0.1% glycerin monooleate aqueous solution, and the content of docosahexaenoic acid did not decrease due to the washing, and other than docosahexaenoic acid. No other polyunsaturated fatty acids were found.
【0025】[0025]
【発明の効果】本発明の方法によると、海洋性微細藻
類、特に、クリプテコディニウム・コーニーの自己消化
物または抽出物を添加した培地中で乳酸菌を培養するこ
とによって、高度不飽和脂肪酸としてドコサヘキサエン
酸のみを含有した乳酸菌が得られ、またこの乳酸菌を効
率良く短時間で製造することが可能となった。INDUSTRIAL APPLICABILITY According to the method of the present invention, lactic acid bacteria are cultivated in a medium supplemented with an autolyzate or extract of marine microalgae, particularly Crypthecodinium cornii, to give polyunsaturated fatty acids. A lactic acid bacterium containing only docosahexaenoic acid was obtained, and this lactic acid bacterium can be efficiently produced in a short time.
Claims (5)
キサエン酸のみを含有することを特徴とするドコサヘキ
サエン酸を含有する乳酸菌。1. A lactic acid bacterium containing docosahexaenoic acid, which contains substantially only docosahexaenoic acid as a highly unsaturated fatty acid.
した培地で乳酸菌を培養することを特徴とするドコサヘ
キサエン酸を含有する乳酸菌の製造方法。2. A method for producing a lactic acid bacterium containing docosahexaenoic acid, which comprises culturing the lactic acid bacterium in a medium containing an autolysate of an alga body of marine microalgae.
した培地で乳酸菌を培養することを特徴とするドコサヘ
キサエン酸を含有する乳酸菌の製造方法。3. A method for producing a lactic acid bacterium containing docosahexaenoic acid, which comprises culturing the lactic acid bacterium in a medium to which an extract from an algal body of a marine microalga is added.
ウム・コーニー(Crypthecodiniumcohnii)である請求
項2または3に記載のドコサヘキサエン酸を含有する乳
酸菌の製造方法。4. The method for producing a lactic acid bacterium containing docosahexaenoic acid according to claim 2 or 3, wherein the marine microalgae is Crypthecodinium cohnii.
水混合物、ヘキサン、エタノール/ヘキサン混合物、メ
タノール/クロロホルム混合物またはメタノール/水混
合物のいずれか1種または2種以上の溶媒で抽出された
ものである請求項3に記載のドコサヘキサエン酸を含有
する乳酸菌の製造方法。5. The extract is ethanol, ethanol /
The lactic acid bacterium containing docosahexaenoic acid according to claim 3, wherein the lactic acid bacterium contains docosahexaenoic acid, which is extracted with one or more solvents selected from a water mixture, hexane, an ethanol / hexane mixture, a methanol / chloroform mixture, and a methanol / water mixture. Production method.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP5168980A JPH0723774A (en) | 1993-07-08 | 1993-07-08 | Lactic acid bacterium containing docosahexaenoic acid and method for producing the same |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP5168980A JPH0723774A (en) | 1993-07-08 | 1993-07-08 | Lactic acid bacterium containing docosahexaenoic acid and method for producing the same |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JPH0723774A true JPH0723774A (en) | 1995-01-27 |
Family
ID=15878128
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP5168980A Withdrawn JPH0723774A (en) | 1993-07-08 | 1993-07-08 | Lactic acid bacterium containing docosahexaenoic acid and method for producing the same |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPH0723774A (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5749002A (en) * | 1996-03-01 | 1998-05-05 | Nikon Corporation | Chromatic balancer for flash cameras |
| JP2015126741A (en) * | 2015-03-02 | 2015-07-09 | 株式会社明治 | Method for producing fermented milk |
-
1993
- 1993-07-08 JP JP5168980A patent/JPH0723774A/en not_active Withdrawn
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5749002A (en) * | 1996-03-01 | 1998-05-05 | Nikon Corporation | Chromatic balancer for flash cameras |
| JP2015126741A (en) * | 2015-03-02 | 2015-07-09 | 株式会社明治 | Method for producing fermented milk |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP1642983B1 (en) | Arachidonic acid and methods for the production and use thereof | |
| JP6226601B2 (en) | Preparation of microbial oil | |
| CA2501880C (en) | Process for producing microbial fat or oil having lowered unsaponifiable matter content and said fat or oil | |
| JP6169150B2 (en) | Process for producing highly unsaturated fatty acids using novel strain preservation technology | |
| EP1513941A2 (en) | Preparation of microbial oil containing polyunsaturated fatty acids | |
| CN103882071B (en) | Microbial oil and preparation method thereof | |
| JP2013531494A (en) | Composition containing eicosapentaenoic acid suitable for highly purified | |
| CN105586275B (en) | Mortierella alpina mutant strain, method for producing arachidonic acid oil by using same and arachidonic acid oil | |
| JPH0723774A (en) | Lactic acid bacterium containing docosahexaenoic acid and method for producing the same | |
| JPH05304967A (en) | Lactic acid producing bacterium containing highly unsaturated fatty acids and method for producing the same | |
| JPH08163990A (en) | Oil-and-fat-containing algal bodies and method for producing oil and fat obtained therefrom | |
| JPH0349688A (en) | Preparation of dihomo-gamma-linolenic acid and agent for inhibiting delta5-position unsaturation reaction of fatty acid | |
| CN105713936A (en) | Preparation method of microbe oil | |
| CN104046661A (en) | Method for preparing biological culture medium obtained by converting rapeseed meal via Neuropara and application of method | |
| JP2002335951A (en) | Method for producing lipid-containing yeast | |
| JP2005087194A (en) | Culture containing conjugated highly-unsaturated fatty acid obtained by using microorganism and method for producing fat and oil containing the conjugated highly-unsaturated fatty acid | |
| HK1146736A (en) | Preparation of microbial oil containing polyunsaturated fatty acids | |
| JP2017051106A (en) | Method for producing phospholipids |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A300 | Withdrawal of application because of no request for examination |
Free format text: JAPANESE INTERMEDIATE CODE: A300 Effective date: 20001003 |